Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP000421) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
Kunitz domain Depelstat
|
|||||
| Synonyms |
DX-890
|
|||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Highest Status | Phase II | |||||
| Template Name | BPTI | |||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS043 | [1] , [2] | ||||
| Scaffold Name | Kunitz domain | |||||
| Scaffold Class | Non-Antibody | |||||
| Fold Type | Alpha-Helices + Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Neutrophil elastase | Inhibitor | Cystic fibrosis [ICD-11: CA25.Z]; Acute respiratory distress syndrome [ICD-11: CB00] | Kd: 0.001 nM | Dyax; Debiopharm SA | [1] , [2] | |
| Clinical Trial Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| NCT00455767 | Click to show the Detail | |||||
| Indication | Acute Respiratory Distress Syndrome | |||||
| Phase | Phase II | |||||
| Title | Phase IIA Multicenter 1 Week Treatment, Randomised, Double-Blind, Placebo Controlled Study of Depelestat in Patients Suffering From Acute Respiratory Distress Syndrome | |||||
| Status | Completed | |||||
| Sponsor | Debiopharm International SA | |||||